Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects
Context: Most of the information on remission related factors in Grave's disease are derived from Western literature. It is likely that there may be additional prognostic factors and differences in the postdrug treatment course of Grave's disease in India. Aim: To study factors which predi...
Main Authors: | Neha Singhal, V P Praveen, Nisha Bhavani, Arun S Menon, Usha Menon, Nithya Abraham, Harish Kumar, R V JayKumar, Vasantha Nair, Shanmugha Sundaram, Padma Sundaram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=2;spage=157;epage=161;aulast=Singhal |
Similar Items
-
Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis
by: Fadime Demir
Published: (2020-01-01) -
Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs
by: Shuo‐Yu Wang, et al.
Published: (2020-04-01) -
Clinical features and predictors of remission in children under the age of 7 years with Graves’ disease
by: Yi Gu, et al.
Published: (2020-09-01) -
Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
by: Ari Song, et al.
Published: (2021-06-01) -
Safety and efficacy of technetium-99 methylene diphosphate combined with glucocorticoid for Graves ophthalmopathy
by: Ri-Qiu Chen, et al.
Published: (2016-04-01)